saterinone has been researched along with Cardiac Output, Low in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haverich, A; Scholz, H; Schumacher, C; Wenzlaff, H; Zimmermann, W | 1 |
| Mende, U; Meyer, W; Neumann, J; Nose, M; Schmitz, W; Scholz, H; Starbatty, J; Stein, B; von der Leyen, H; Wenzlaff, H | 1 |
2 other study(ies) available for saterinone and Cardiac Output, Low
| Article | Year |
|---|---|
Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Animals; Cardiac Output, Low; Cardiomyopathy, Dilated; Cardiotonic Agents; Chromatography, DEAE-Cellulose; Female; Heart Ventricles; Humans; In Vitro Techniques; Isoenzymes; Kinetics; Male; Middle Aged; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pyridones; Stereoisomerism; Swine | 1994 |
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Benzimidazoles; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Oxindoles; Phosphodiesterase Inhibitors; Piperazines; Pyridazines; Pyridones | 1991 |